One-year follow-up in a phase 1/2a clinical trial of an allogeneic RPE cell bioengineered implant for advanced dry age-related macular degeneration - Kashani, AH; Lebkowski, JS; Rahhal, FM (Transl Vis Sci Technol, 2021)